![Tablets of Avigan (generic name : Favipiravir), a drug approved as an anti-influenza drug in Japan and developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed Tablets of Avigan (generic name : Favipiravir), a drug approved as an anti-influenza drug in Japan and developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed](https://c8.alamy.com/zooms/6/6edcf2f8fe9b4da19f7289283bcb1001/2cykxa5.jpg)
Tablets of Avigan (generic name : Favipiravir), a drug approved as an anti-influenza drug in Japan and developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed
![Hetero on Twitter: "Our relentless efforts to fight against COVID-19 continue, with the launch of Favipiravir as 'Favivir', the second drug manufactured after Covifor, for the treatment of COVID-19 patients with mild Hetero on Twitter: "Our relentless efforts to fight against COVID-19 continue, with the launch of Favipiravir as 'Favivir', the second drug manufactured after Covifor, for the treatment of COVID-19 patients with mild](https://pbs.twimg.com/media/EeGEkKZUEAEC-gi.jpg:large)
Hetero on Twitter: "Our relentless efforts to fight against COVID-19 continue, with the launch of Favipiravir as 'Favivir', the second drug manufactured after Covifor, for the treatment of COVID-19 patients with mild
![Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial - ScienceDirect Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S120197122032453X-gr1.jpg)